Table 3 Raw and age- and sex-adjusted prevalence ratios of comorbidities in RA patients compared to non-RA individuals who consumed any resources during 2018

Neoplasms

Colorectal Neoplasms

3.09 (2.91–3.27)

1.90 (1.79–2.01)

Lung Neoplasms

4.09 (3.7–4.52)

2.38 (2.15–2.63)

Skin Neoplasms

2.76 (2.67–2.85)

1.68 (1.63–1.74)

Endocrine

Hypothyroidism

3.33 (3.3–3.36)

1.94 (1.92–1.96)

Diabetes

2.73 (2.7–2.76)

1.64 (1.62–1.65)

Psychiatric

Depression

3.56 (3.49–3.62)

2.39 (2.35–2.43)

Anxiety

2.64 (2.6–2.68)

1.82 (1.79–1.85)

Neurologic

Parkinson’s Disease

2.88 (2.69–3.07)

1.70 (1.59–1.82)

Multiple Sclerosis

10.04 (9.24–10.89)

7.18 (6.6–7.82)

Migraine

1.20 (1.18–1.22)

1.27 (1.25–1.29)

Cardiovascular

Hyperlipidemia

1.80 (1.78–1.82)

1.21 (1.2–1.22)

Hypertension

2.60 (2.59–2.62)

1.61 (1.6–1.62)

Angina

2.79 (2.7–2.88)

1.76 (1.7–1.82)

Acute Myocardial Infarction

4.11 (4-4.24)

2.79 (2.7–2.87)

Coronary Artery Disease

2.76 (2.69–2.83)

1.78 (1.74–1.82)

Arrhythmias

2.58 (2.51–2.65)

1.55 (1.51–1.59)

Heart Failure

3.47 (3.37–3.58)

2.02 (1.96–2.08)

Stroke

3.04 (2.87–3.22)

1.80 (1.7–1.91)

Pulmonary

Chronic Sinusitis

2.55 (2.48–2.63)

2.00 (1.94–2.06)

Chronic Bronchitis

3.02 (2.9–3.13)

1.77 (1.71–1.84)

Emphysema

4.42 (3.88–5.03)

2.78 (2.44–3.17)

COPD

4.05 (3.98–4.12)

2.24 (2.2–2.27)

Asthma

2.42 (2.37–2.48)

1.88 (1.84–1.93)

Gastrointestinal

GERD

2.71 (2.67–2.76)

1.89 (1.85–1.92)

Gastric Ulcer

3.68 (3.43–3.96)

2.47 (2.3–2.66)

Gastritis

2.29 (2.27–2.31)

1.76 (1.75–1.78)

Inflammatory Bowel Disease

1.48 (1.44–1.51)

1.54 (1.5–1.58)

Diverticulitis

4.07 (3.89–4.25)

2.18 (2.08–2.27)

Skin

Eczema

1.85 (1.82–1.87)

1.62 (1.6–1.64)

Psoriasis

5.97 (5.76–6.19)

5.04 (4.86–5.23)

Sebaceous Gland Disorders

0.82 (0.79–0.86)

1.79 (1.71–1.87)

Musculoskeletal

Osteoarthritis

5.49 (5.45–5.52)

2.83 (2.81–2.86)

Lupus

37.89 (37.06–38.73)

30.04 (29.29–30.82)

Discopathy

2.92 (2.88–2.96)

2.07 (2.04–2.1)

Osteoporosis

13.24 (13.07–13.41)

5.57 (5.5–5.64)

Urogenital

Urolithiasis

1.34 (1.31–1.37)

1.43 (1.4–1.46)

Cystitis

1.85 (1.8–1.89)

1.36 (1.33–1.39)